Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Cardiff Oncology, Inc. | a322exq42020.htm |
| EX-32.1 - EX-32.1 - Cardiff Oncology, Inc. | a321exq42020.htm |
| EX-31.2 - EX-31.2 - Cardiff Oncology, Inc. | a312exq42020.htm |
| EX-31.1 - EX-31.1 - Cardiff Oncology, Inc. | a311exq42020.htm |
| EX-10.17 - EX-10.17 - Cardiff Oncology, Inc. | a1017ex022321.htm |
| EX-10.16 - EX-10.16 - Cardiff Oncology, Inc. | a1016ex022521.htm |
| EX-10.9 - EX-10.9 - Cardiff Oncology, Inc. | a109ex022521.htm |
| 10-K - 10-K - Cardiff Oncology, Inc. | trov-20201231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Cardiff Oncology, Inc.
San Diego, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S-1 (Nos. 333-239464, 333-238623, 333-234442, and 333-233568), Form S-3 (Nos. 333-232321, 333-229693) and Form S-8 (Nos. 333-239725 and 333-232363) of Cardiff Oncology, Inc. (the “Company”) of our report dated February 25, 2021, relating to the financial statements which appears in this Annual Report form 10-K.
/s/ BDO USA, LLP
San Diego, California
February 25, 2021